BioSpace News Archive

Pharm Country

AMC Health Unveils Their 360-degree Patient View, Including New Website, Social and Digital Health Care Engagement

AMC Health, a leader in virtual healthcare delivery solutions, is pleased to announce the launch of its newly redesigned website at https://www.amchealth.com.

October 17, 2019
·
4 min read
Policy

ASP Framework Points the Way Forward For Building National, Multi-Disciplinary Key Stakeholder Collaboration In Precision Medicine

American Society of Pharmacovigilance directors presented to key stakeholders in the field of pharmacogenomics, a detailed framework for building a national, public-private multi-disciplinary stakeholder collaboration to accelerate the development of precision medicine practices as a standard of care.

October 17, 2019
·
1 min read
Biotech Beach

INmune Bio, Inc. Announces Presentation of Data Related to its Lead Compound XPro1595 at the Society for Neuroscience’s Annual Meeting

Data on Neuroinflammation and Alzheimer’s Disease to be Presented by Dr. Malú Tansey; Presentation Selected for Meeting’s Press Conference

October 17, 2019
·
5 min read
BioMidwest

Welltower Achieves ISS ESG Prime Status for 2019

In addition to Prime status, with this evaluation, Welltower achieved a decile rank of 1, indicating the highest ESG performance rating in its industry group.

October 17, 2019
·
3 min read
Pharm Country

Talc powder exposure linked to mesothelioma

The first large-scale published case study connects the cause of malignant mesothelioma to household talcum powder contaminated with asbestos

October 17, 2019
·
3 min read
Drug Development

Bird Rock Bio Announces Successful Completion of Phase 1B Safety Study and Readiness for Phase 2B Study of Nimacimab in Patients with Diabetic Kidney Disease

Nimacimab is a first-in-class negative-allosteric modulating antibody agonist to the cannabinoid 1 (CB1) receptor.

October 17, 2019
·
3 min read
Envirotainer Opens RAP e2 Station in Liège (LGG)

Envirotainer announced that they are upgrading their network of stations supporting their state-of-the-art e-technology container, the RAP e2, by adding Liège

October 17, 2019
·
1 min read
Policy

[Fam-] Trastuzumab Deruxtecan (DS-8201) Granted FDA Priority Review for Treatment of Patients with HER2 Positive Metastatic Breast Cancer

Daiichi Sankyo Company, Limited and AstraZeneca announced that the U.S. Food and Drug Administration has accepted for review the Biologics License Application for [fam-] trastuzumab deruxtecan and granted Priority Review..

October 17, 2019
·
8 min read
Drug Development

Dermira Presents Data From Phase 2b Study of Lebrikizumab in Patients With Atopic Dermatitis at Fall Clinical Dermatology Conference

Lebrikizumab demonstrated dose-dependent improvements across endpoints spanning the range of atopic dermatitis signs and symptoms, including skin lesions and pruritus, when administered once every two or four weeks

October 17, 2019
·
13 min read
Business

R1 RCM to Release Third Quarter 2019 Results on November 5

A live webcast and replay of the call will be available at the Investor Relations section of the Company’s website at r1rcm.com.

October 17, 2019
·
1 min read